British biopharma start-up Mereo to list in London

LONDON, June 6 (Reuters) - Mereo BioPharma Group, a British company trialing three drugs developed by Novartis , said it would list on London's junior AIM market to raise capital to develop its drugs and give it more financial flexibility for further deals.

from Reuters: New Issues News http://ift.tt/1U2Sz6O